These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Kawasaki disease shock syndrome: clinical characteristics and possible use of IL-6, IL-10 and IFN-γ as biomarkers for early recognition. Li Y; Zheng Q; Zou L; Wu J; Guo L; Teng L; Zheng R; Jung LKL; Lu M Pediatr Rheumatol Online J; 2019 Jan; 17(1):1. PubMed ID: 30611297 [TBL] [Abstract][Full Text] [Related]
4. Kawasaki disease shock syndrome: Unique and severe subtype of Kawasaki disease. Gamez-Gonzalez LB; Moribe-Quintero I; Cisneros-Castolo M; Varela-Ortiz J; Muñoz-Ramírez M; Garrido-García M; Yamazaki-Nakashimada M Pediatr Int; 2018 Sep; 60(9):781-790. PubMed ID: 29888440 [TBL] [Abstract][Full Text] [Related]
5. Hyponatremia in Kawasaki disease. Watanabe T; Abe Y; Sato S; Uehara Y; Ikeno K; Abe T Pediatr Nephrol; 2006 Jun; 21(6):778-81. PubMed ID: 16565868 [TBL] [Abstract][Full Text] [Related]
6. Kawasaki disease shock syndrome: case report. Yang HF; Chen WL; Chang CN; Chen SJ; Fan HC Paediatr Int Child Health; 2016 Feb; 36(1):76-8. PubMed ID: 25695906 [TBL] [Abstract][Full Text] [Related]
8. Clinical aspects for differential diagnosis of Kawasaki disease shock syndrome: a case control study. Park WY; Lee SY; Kim GB; Song MK; Kwon HW; Bae EJ; Choi EH; Park JD BMC Pediatr; 2021 Jan; 21(1):25. PubMed ID: 33413220 [TBL] [Abstract][Full Text] [Related]
9. Kawasaki Disease and Kawasaki Disease Shock Syndrome Hospitalization Rates in the United States, 2006-2018. Maddox RA; Person MK; Kennedy JL; Leung J; Abrams JY; Haberling DL; Schonberger LB; Belay ED Pediatr Infect Dis J; 2021 Apr; 40(4):284-288. PubMed ID: 33264213 [TBL] [Abstract][Full Text] [Related]
10. Syndrome of inappropriate anti-diuretic hormone in Kawasaki disease. Mori J; Miura M; Shiro H; Fujioka K; Kohri T; Hasegawa T Pediatr Int; 2011 Jun; 53(3):354-7. PubMed ID: 21029251 [TBL] [Abstract][Full Text] [Related]
11. Kawasaki disease shock syndrome complicated with macrophage activation syndrome in a 5-month old boy: A case report. Lin Y; Shi L; Deng YJ; Liu Y; Zhang HW Medicine (Baltimore); 2019 Jan; 98(4):e14203. PubMed ID: 30681594 [TBL] [Abstract][Full Text] [Related]
12. Clinical manifestations associated with Kawasaki disease shock syndrome in Mexican children. Gámez-González LB; Murata C; Muñoz-Ramírez M; Yamazaki-Nakashimada M Eur J Pediatr; 2013 Mar; 172(3):337-42. PubMed ID: 23152158 [TBL] [Abstract][Full Text] [Related]
13. Describing Kawasaki shock syndrome: results from a retrospective study and literature review. Taddio A; Rossi ED; Monasta L; Pastore S; Tommasini A; Lepore L; Bronzetti G; Marrani E; Mottolese BD; Simonini G; Cimaz R; Ventura A Clin Rheumatol; 2017 Jan; 36(1):223-228. PubMed ID: 27230223 [TBL] [Abstract][Full Text] [Related]
14. Early Differentiation of Kawasaki Disease Shock Syndrome and Toxic Shock Syndrome in a Pediatric Intensive Care Unit. Lin YJ; Cheng MC; Lo MH; Chien SJ Pediatr Infect Dis J; 2015 Nov; 34(11):1163-7. PubMed ID: 26222065 [TBL] [Abstract][Full Text] [Related]
15. Kawasaki disease and hyponatremia. Shin JI; Kim JH; Lee JS; Kim DS; Choi JY; Sul JH Pediatr Nephrol; 2006 Oct; 21(10):1490-1; author reply 1492. PubMed ID: 16896998 [No Abstract] [Full Text] [Related]
16. Kawasaki disease shock syndrome with acute respiratory distress syndrome in a child: a case report and literature review. Liu J; Yang C; Zhang Z; Li Y BMC Pulm Med; 2022 Jun; 22(1):220. PubMed ID: 35668424 [TBL] [Abstract][Full Text] [Related]
17. [Kawasaki disease shock syndrome: a case report]. Vieni G; Pusceddu S; Bruno I; Ragni L; Marchetti F G Ital Cardiol (Rome); 2018 Feb; 19(2):111-114. PubMed ID: 29531383 [TBL] [Abstract][Full Text] [Related]
18. Comparison of Clinical Features and Inflammatory Markers between Kawasaki Disease Shock Syndrome and Kawasaki Disease without Shock: A Meta-Analysis. Zhang H; Zheng Q; Li F J Healthc Eng; 2021; 2021():1486089. PubMed ID: 34966519 [TBL] [Abstract][Full Text] [Related]
19. Kawasaki Disease Shock Syndrome vs Classical Kawasaki Disease: A Meta-analysis and Comparison With SARS-CoV-2 Multisystem Inflammatory Syndrome. Lamrani L; Manlhiot C; Elias MD; Choueiter NF; Dionne A; Harahsheh AS; Portman MA; McCrindle BW; Dahdah N Can J Cardiol; 2021 Oct; 37(10):1619-1628. PubMed ID: 34090979 [TBL] [Abstract][Full Text] [Related]
20. Significance of hyponatremia in Kawasaki disease. Tsuji S Pediatr Int; 2020 Mar; 62(3):307. PubMed ID: 32246568 [No Abstract] [Full Text] [Related] [Next] [New Search]